← Back to patent-cliff list
Bepecin
Tier C — Watch / tradeBepecin
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：肌肉损伤, 肩袖损伤
Regional status
US
Phase I
2026-08-12
EU
-
China
Phase II
2026-02-02
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bepecin?
Approved indications include: 肌肉损伤, 肩袖损伤.
When does the Bepecin patent expire?
No public expiry year is available for Bepecin yet; this page updates once verified.
How do I get a quote for Bepecin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29